Kosten Digital Launches in the U.S. to Transform Life Sciences with Custom AI Solutions, Welcomes Industry Leader Amy DuRoss to Advisory Board

Amy DuRoss, former CEO of Vineti, joins Advisory Board to help Kosten Digital expand its markets and integrate its AI solutions with life science partners

Boca Raton, Florida, September 4, 2024 –  Kosten Digital, a leading developer of custom AI and digital solutions for the healthcare industry, has officially launched in the United States to drive the digital transformation of life sciences and healthcare companies.

The company is also delighted to announce the strategic appointment of Amy DuRoss, co-founder and former CEO of Vineti, to its Advisory Board. Her addition, alongside co-founders Claudia Zylberberg, Ph.D., and Edy Resnik, is a significant step in the company’s strategic alignment and expansion into North American and European markets.

Backed by personnel with over 40 years of experience, Kosten is rapidly becoming a leader in software development and digital solutions. The company has utilized the extensive experience of its co-founders in life sciences, IT, and advanced therapies to tackle challenges like integrating data for global organizations, organizing cell banking data, predicting emergency room visits, and detecting cancer, to name a few.

Kosten Digital stands out with its bespoke digital services, offering unique solutions to biopharmaceutical companies, hospitals, diagnostic developers, and service providers. These services are designed to efficiently harness vast data sets for product innovation, a key factor in the success of global biotech companies, cell banks, public health agencies, and hospitals.

"We're excited to have Amy join us at a crucial time when the life sciences industry and academia are grappling with the challenges of managing growing volumes of data," said Daniel Merkier, CEO of Kosten Digital. "Our AI technologies are primed to optimize cell and gene therapy development and manufacturing, making life-saving medicines more affordable and accessible."

"The life sciences sector is undergoing significant transformation, driven by AI and evolving stakeholder needs," said DuRoss. "Kosten Digital is well-positioned to meet the growing demand for digital transformation, data science, and security solutions."

About Kosten Digital
Kosten Digital’s mission is to revolutionize life sciences through digital transformation. Founded by Claudia Zylberberg, Edy Resnik and Mariano Tribuj, the company is reshaping how technology solutions are built to foster innovation. Kosten Digital develops custom technology solutions that help life sciences organizations optimize operations, capitalize on data, and innovate more effectively through AI. From early-stage startups to global corporations, we meet clients wherever they are on their digital journey. For more information, visit kostendigital.com.

About Amy DuRoss
Amy DuRoss brings decades of leadership experience in regenerative medicine, advanced therapies, and personalized medicine to Kosten’s Advisory Board. Currently, she is a senior advisor at Frazier Healthcare Partners and Synapticure Inc., and sits on the boards of BioLife Solutions, ARM Foundation for Cell & Gene Medicine, and MJH Life Sciences. Previously, she co-founded and served as CEO of Vineti, a digital platform provider for cell and gene therapy supply chains.